Skip to main content

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY: PLX )

1.760 +0.020 (+1.15%)
Official Closing Price Updated: 8:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
November 30, 2011
Form 8-K
Source: SEC/Edgar
November 09, 2011
Form 8-K
Source: SEC/Edgar
November 07, 2011
Form 8-K
Source: SEC/Edgar
October 25, 2011
Form ARS
Source: SEC/Edgar
September 22, 2011
Form 8-K
Source: SEC/Edgar
September 20, 2011
Form DEF 14A
Source: SEC/Edgar
September 18, 2011
Form 8-K
Source: SEC/Edgar
September 12, 2011
Form 8-K
Source: SEC/Edgar
September 07, 2011
Form 8-K
Source: SEC/Edgar
August 16, 2011
Form 8-K
Source: SEC/Edgar
July 31, 2011
Form 8-K
Source: SEC/Edgar
June 14, 2011
Form 8-K
Source: SEC/Edgar
May 11, 2011
Form 8-K
Source: SEC/Edgar
April 26, 2011
Form 8-K
Source: SEC/Edgar
April 06, 2011
Form 8-K/A
Source: SEC/Edgar
March 22, 2011
Form 8-K
Source: SEC/Edgar
March 17, 2011
Form 424B5
Source: SEC/Edgar
March 17, 2011
Form 8-K
Source: SEC/Edgar
March 16, 2011
Form 424B5
Source: SEC/Edgar
March 16, 2011
Form 8-K
Source: SEC/Edgar
February 24, 2011
Form 8-K
Source: SEC/Edgar
February 17, 2011
Form SC 13G/A
Source: SEC/Edgar
February 13, 2011
Form 8-K
Source: SEC/Edgar
January 26, 2011
Form SC 13G
Source: SEC/Edgar
January 24, 2011
Form 8-K
Source: SEC/Edgar
January 23, 2011
Form SC 13D/A
Source: SEC/Edgar
January 19, 2011
Form 8-K
Source: SEC/Edgar
January 18, 2011
Form EFFECT
Source: SEC/Edgar
January 12, 2011
Form S-3
Source: SEC/Edgar
January 09, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.